CLINICAL_TRIALS
trial_result
· 2024-02-29
Clinical Trial Update: A Dose Finding Study of VN-0200 [Phase 2]
Summary
Phase 2 dose-finding trial of VN-0200 for respiratory syncytial virus infections has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED